Price: $499.00 – $2,199.00 (Depending on gift card add-on level)
Access: 12 months of unlimited 24/7 online access
Deliverables: 100 Hours of AAPA Category 1 CME Credit (PANRE Review) or AAPA Category 1 Pharmacology Credit
Content: Over 1,000 high-yield practice questions and clinical blueprint review modules
If you are a Physician Assistant (PA) with a CME budget that expires at the end of this quarter, you are likely asking one question: Can I still get a gift card with my CME purchase in 2026? With changing regulations and employer oversight, many clinicians are worried that the days of the "Amazon CME gift card" are over.
The short answer is yes, you can still purchase CME with a gift card add-on, but you have to be smarter about how you do it. At CME Review Courses, we have designed our system to be compliant, educational, and employer-friendly. This post will break down the legality of these packages and how to maximize your 2026 CME allowance while preparing for your PANRE or PANRE-LA.
The Legality of CME Gift Cards in 2026
The primary concern regarding CME gift cards often comes down to two areas: IRS regulations and employer reimbursement policies.
IRS and Tax Considerations
From a tax perspective, the IRS has long maintained that gift cards are considered "cash equivalents." This means that if your employer pays for a course that includes a $1,500 Amazon gift card, that gift card value is technically considered taxable income to you. As of April 2026, these rules remain in place. It is the responsibility of the individual clinician to report these items according to their local tax laws and personal financial situation.
Employer Reimbursement Policies
Most hospital systems and private practices are happy to pay for your education. They want you to maintain your certification and stay up to date on the latest clinical guidelines. However, many HR departments flag receipts that explicitly list "Gift Card" as a line item. They do this to avoid the appearance of providing tax-free bonuses to employees.
The "Clean" Receipt System
This is where CME Review Courses excels. We provide what we call a "clean" receipt. When you purchase one of our CME with Gift Card packages, your receipt reflects the total cost of the educational program. It lists the AAPA Category 1 Credit hours and the course name (e.g., PANRE Review Course). This makes the reimbursement process seamless. Your employer sees a high-value educational investment, and you receive the educational tools: and the gift card add-on: you need to further your professional development.
Maximize Your Budget: $100 to $1,500 Add-ons
We offer the most flexible gift card options in the industry. Whether you have a small remaining balance or a full $2,500 annual allowance, you can tailor your purchase. We offer Amazon and Apple gift card add-ons ranging from $100 to $1,500.
These add-ons are integrated into our PANRE Review Course, which provides 100 hours of AAPA Category 1 Credit. This is the most efficient way to knock out your entire recertification requirement in one shot while also securing funds for clinical tools, medical textbooks, or the latest hardware to run your practice apps.
High-Yield Content Written by PAs for PAs
Unlike many generic board review programs, our content is written by PAs who have actually sat for the PANRE and PANRE-LA. We cover the core blueprint categories that matter most to your practice and your exam:
- Emergency Medicine
- Family Medicine
- Internal Medicine (Hospitalist focus)
- Orthopedics
- Dermatology
- Psychiatry
- Neurology
- Cardiology
- OB/GYN
While our primary audience is physician assistants, we frequently see nurse practitioners and physicians purchase our Orthopedics CME Package and other specialty modules. While the credit is AAPA Category 1, many state nursing boards and medical boards accept these credits toward Category 2 or general education requirements.
Clinical Review: High-Yield Practice Scenarios
The following scenarios are designed to test your clinical knowledge across multiple specialties using the current medical standards as of April 2026.
Case Scenario 1: Cardiology
Your patient is a 64-year-old male presenting to the emergency department with a 2-hour history of substernal chest pain. He describes the pain as "heavy" and radiating to his left jaw. He is diaphoretic and nauseated. His past medical history includes hypertension, type 2 diabetes, and tobacco use.
Vital Signs: BP 142/88 mmHg, HR 98 bpm, SaO2 96% on RA, Temp 98.6°F.
EKG: Shows 2mm ST-segment elevation in leads II, III, and aVF.
Which of the following is the most appropriate next step in management?
A. Administer 324 mg of chewable aspirin and activate the cardiac catheterization lab.
B. Obtain a STAT portable chest X-ray to rule out aortic dissection.
C. Order a high-sensitivity troponin and wait for results before treatment.
D. Administer sublingual nitroglycerin and discharge if the pain resolves.
Correct Answer: A. Administer 324 mg of chewable aspirin and activate the cardiac catheterization lab.
Explanation: This patient is presenting with an inferior wall ST-elevation myocardial infarction (STEMI). In the setting of a STEMI, time is muscle. The standard of care is immediate reperfusion therapy. Aspirin should be administered immediately (unless contraindicated) to inhibit further platelet aggregation. Activation of the cath lab for primary percutaneous coronary intervention (PCI) is the priority. Delaying for troponin results (Choice C) is inappropriate when the EKG is diagnostic. While a chest X-ray (Choice B) is often part of the workup, it should not delay the transport of a STEMI patient to the cath lab. Nitroglycerin (Choice D) may help with pain, but it is not definitive treatment and must be used with caution in inferior MIs due to potential right ventricular involvement and subsequent hypotension.
Case Scenario 2: Orthopedics
Your patient is a 19-year-old female athlete who presents with acute right knee pain after landing awkwardly from a jump during a basketball game. She felt a "pop" and experienced immediate swelling. She is unable to fully extend the knee and is walking with a significant limp.
Physical Exam: Significant joint effusion is noted. The Lachman test is positive with a soft endpoint. The anterior drawer test is also positive. McMurray's test is negative for joint line tenderness.
What is the most likely diagnosis?
A. Medial Meniscus Tear
B. Anterior Cruciate Ligament (ACL) Rupture
C. Medial Collateral Ligament (MCL) Strain
D. Patellar Tendon Rupture
Correct Answer: B. Anterior Cruciate Ligament (ACL) Rupture
Explanation: The clinical triad of a "pop," immediate swelling (hemarthrosis), and an unstable knee after a non-contact pivoting or landing injury is classic for an ACL tear. The Lachman test is the most sensitive physical exam maneuver for confirming an ACL rupture. While a meniscus tear (Choice A) can occur concurrently (O’Donoghue’s Triad), the positive Lachman and immediate effusion point specifically to the ACL. MCL strains (Choice C) typically present with valgus stress tenderness rather than a positive Lachman. Patellar tendon rupture (Choice D) would present with a high-riding patella (patella alta) and an inability to perform a straight leg raise, which is not described here. For more in-depth review, see our Musculoskeletal Blueprint Review.
Case Scenario 3: Endocrinology/Pharmacology
Your patient is a 52-year-old female with a 5-year history of Type 2 Diabetes Mellitus. Her current A1c is 8.2% despite adherence to Metformin 1000mg BID. She has a BMI of 34 kg/m² and a history of stable atherosclerotic cardiovascular disease (ASCVD). She is interested in a medication that might also help her lose weight.
Based on the 2026 standards of care, which class of medication is the most appropriate addition to her regimen?
A. Sulfonylureas (e.g., Glipizide)
B. GLP-1 Receptor Agonists (e.g., Semaglutide)
C. DPP-4 Inhibitors (e.g., Sitagliptin)
D. Thiazolidinediones (e.g., Pioglitazone)
Correct Answer: B. GLP-1 Receptor Agonists (e.g., Semaglutide)
Explanation: For patients with Type 2 Diabetes and established ASCVD, GLP-1 receptor agonists or SGLT2 inhibitors are recommended as high-priority additions due to their proven cardiovascular benefits. Furthermore, GLP-1 RAs provide significant weight loss benefits, which aligns with this patient's goals. Sulfonylureas (Choice A) are associated with weight gain and hypoglycemia. DPP-4 inhibitors (Choice C) are weight-neutral and do not offer the same cardiovascular protection. Thiazolidinediones (Choice D) can cause weight gain and fluid retention, making them less ideal for this patient.
Conclusion
Staying current in 2026 requires both clinical excellence and financial savvy. Whether you are preparing for the PANRE-LA or simply need to fulfill your 100 hours of AAPA Category 1 credit, our courses provide the highest return on investment. By utilizing our "clean" receipt system and flexible gift card add-ons, you can ensure your CME money is working as hard as you are.
Don't leave your CME funds on the table. Explore our CME with Gift Card packages today.